SG11201806985WA - Methods and reagents for prevention and/or treatment of infection - Google Patents

Methods and reagents for prevention and/or treatment of infection

Info

Publication number
SG11201806985WA
SG11201806985WA SG11201806985WA SG11201806985WA SG11201806985WA SG 11201806985W A SG11201806985W A SG 11201806985WA SG 11201806985W A SG11201806985W A SG 11201806985WA SG 11201806985W A SG11201806985W A SG 11201806985WA SG 11201806985W A SG11201806985W A SG 11201806985WA
Authority
SG
Singapore
Prior art keywords
hospitalet
international
reynals
idibell
llobregat
Prior art date
Application number
SG11201806985WA
Other languages
English (en)
Inventor
Mendiluce Rafael Mañez
Vallés Cristina Costa
Cruz Magdiel Pérez
Gil Daniel Bello
Original Assignee
Inst Dinvestigacio Biomedica De Bellvitge Idibell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Dinvestigacio Biomedica De Bellvitge Idibell filed Critical Inst Dinvestigacio Biomedica De Bellvitge Idibell
Publication of SG11201806985WA publication Critical patent/SG11201806985WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
SG11201806985WA 2014-08-22 2015-08-24 Methods and reagents for prevention and/or treatment of infection SG11201806985WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14382324.3A EP2987503A1 (en) 2014-08-22 2014-08-22 Methods and reagents for prevention and/or treatment of infection
PCT/EP2015/069334 WO2016026981A1 (en) 2014-08-22 2015-08-24 Methods and reagents for prevention and/or treatment of infection

Publications (1)

Publication Number Publication Date
SG11201806985WA true SG11201806985WA (en) 2018-09-27

Family

ID=51485539

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201806985WA SG11201806985WA (en) 2014-08-22 2015-08-24 Methods and reagents for prevention and/or treatment of infection

Country Status (12)

Country Link
EP (2) EP2987503A1 (ja)
JP (1) JP6612346B2 (ja)
KR (1) KR102492850B1 (ja)
CN (1) CN107073020B (ja)
AU (1) AU2015305108B2 (ja)
CA (1) CA2958600C (ja)
ES (1) ES2759565T3 (ja)
MX (1) MX2017002385A (ja)
PL (1) PL3183003T3 (ja)
RU (1) RU2698099C2 (ja)
SG (1) SG11201806985WA (ja)
WO (1) WO2016026981A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018365250B2 (en) 2017-11-10 2022-05-26 The Johns Hopkins University Dendrimer delivery system and methods of use thereof
CN108646029B (zh) * 2018-05-14 2021-07-02 中国食品药品检定研究院 人抗-Gal-IgG抗体检测试剂盒及其制备方法和用途
EP3964235A1 (en) * 2020-09-08 2022-03-09 RemAb Therapeutics SL Glycoconjugates and medical uses thereof
WO2023138211A1 (zh) * 2022-01-21 2023-07-27 苏州万维生命科学技术有限公司 星型β-抗菌糖肽、其制备方法及应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK131083A (da) * 1982-03-23 1983-09-24 Svenska Sockerfabriks Ab Fremgangsmaade til fremstilling af terapeutiske eller diagnostiske praeparater
US5262165A (en) 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
US6010715A (en) 1992-04-01 2000-01-04 Bertek, Inc. Transdermal patch incorporating a polymer film incorporated with an active agent
AUPM623994A0 (en) * 1994-06-15 1994-07-07 Biomolecular Research Institute Limited Antiviral dendrimers
HU228434B1 (en) 1995-06-07 2013-03-28 Ortho Mcneil Pharm Inc Transdermal medicament for administering 17-deacetyl norgestimate alone or in combination with an estrogen
CA2284729A1 (en) * 1997-04-18 1998-10-29 Novartis Ag Neoglycoproteins
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
AU761831B2 (en) * 1998-04-15 2003-06-12 Bioscience 2002 Llc Inhibition of xenoreactive antibodies
CA2396966A1 (en) * 2000-01-13 2001-07-19 John Papageorgiou Methods for synthesis of .alpha.-d-gal (1.fwdarw.3) gal-containing oligosaccharides
EP2230249A3 (en) * 2003-02-06 2010-12-22 ChronTech Pharma AB Antigen/antibody or ligand/receptor glycosylated specificity exchangers
AU2003901008A0 (en) 2003-03-04 2003-03-20 Anadis Ltd Composition for the treatment and prevention of bacterial infections
US7915235B2 (en) * 2006-03-20 2011-03-29 Brian Dieckgraefe High affinity ligands bind to clostridium difficile toxin A
US8361441B2 (en) 2008-03-11 2013-01-29 Taipei Medical University Detection and therapy of bacterial infection caused by Enterobacteriaceae
US7928077B2 (en) * 2008-07-11 2011-04-19 Academia Sinica Alpha-galactosyl ceramide analogs and their use as immunotherapies

Also Published As

Publication number Publication date
KR20170043556A (ko) 2017-04-21
PL3183003T3 (pl) 2020-03-31
CN107073020A (zh) 2017-08-18
RU2017108569A (ru) 2018-09-24
ES2759565T3 (es) 2020-05-11
WO2016026981A1 (en) 2016-02-25
EP2987503A1 (en) 2016-02-24
RU2698099C2 (ru) 2019-08-22
AU2015305108B2 (en) 2021-03-18
JP6612346B2 (ja) 2019-11-27
RU2017108569A3 (ja) 2019-03-13
CA2958600C (en) 2023-01-10
JP2017525763A (ja) 2017-09-07
EP3183003A1 (en) 2017-06-28
AU2015305108A1 (en) 2017-04-06
CA2958600A1 (en) 2016-02-25
MX2017002385A (es) 2017-06-30
KR102492850B1 (ko) 2023-01-26
EP3183003B1 (en) 2019-07-31
CN107073020B (zh) 2019-12-10

Similar Documents

Publication Publication Date Title
SG11201907034PA (en) Methods of treating influenza
SG11201909963YA (en) Methods for treating dravet syndrome
SG11201906431UA (en) Method for the treatment of thromboembolism
SG11201804312RA (en) Microbubble-chemotherapeutic agent complex for sonodynamic therapy
SG11201803686UA (en) Prodrugs of a jak inhibitor compound for treatment of gastrointestinal inflammatory disease
SG11201407340YA (en) Treatment of myelosuppression
SG11201811019TA (en) Device for cardiac valve repair and method of implanting the same
SG11201808539WA (en) Mouth piece for cooling of oral tissue of a patient during chemotherapy treatment
SG11201807809XA (en) A transient commensal microorganism for improving gut health
SG11201806868TA (en) Compositions and methods for protecting against airborne pathogens and irritants
SG11201808222RA (en) Methods of treatment of cholestatic diseases
SG11201807913XA (en) Stabilized soluble pre-fusion rsv f proteins
SG11201810280YA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201408459VA (en) Purification of virus like particles
SG11201809908TA (en) Stabilized glycopeptide antibiotic formulations
SG11201906436VA (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
SG11201809341PA (en) Mobile robot
SG11201900551WA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201810786RA (en) [bis(trihydrocarbylsilyl)aminosilyl]-functionalized styrene and a method for its preparation
SG11201806985WA (en) Methods and reagents for prevention and/or treatment of infection
SG11201805311XA (en) Method of treating a mammal, including human, against cancer using methionine and asparagine depletion
SG11201901374WA (en) Antibiotic compounds
SG11201900021PA (en) Methods and compositions for the treatment of cancer
SG11201807963WA (en) Compositions useful in the prevention and/or treatment of disorders of the oral cavity, upper airways and esophagus
SG11201407536UA (en) Topical pharmaceutical compositions comprising terbinafine and urea